Drugs used in Diabets

Filters
Category
Release Form
Primary Package
Status
Dossier Type
Search

Drugs used in Diabetes

Dapagliflozin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

5mg, 10mg

Blister, Rx, EU CTD
More Less

Dapagliflozin + Metformin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

5mg+850mg, 5mg+1000mg

Blister, Rx, EU CTD
More Less

Dextrose

Drugs used in Diabetes

Unit Dose Powder for oral solution

Unit Dose Powder for oral solution

75g

Sachet, MD, Tech File
More Less

Empagliflozin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

10mg, 25mg

Blister, Rx, EU CTD
More Less

Empagliflozin + Metformin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

12.5mg+850mg, 12.5mg+1000mg

Blister, Rx, EU CTD
More Less

Gliclazide

Drugs used in Diabetes

Tablets modified release (MR)

Tablets modified release (MR)

60mg

Blister, Rx, CTD
More Less

Glimepiride

Drugs used in Diabetes

Tablets

Tablets

2mg, 3mg, 4mg

Blister, Rx, CTD
More Less

Ipragliflozin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

50mg

Blister, Rx, ICH
More Less

Metformin

Drugs used in Diabetes

Film-coated Tablets Tablets prolong. action (XR)

Film-coated Tablets

500mg, 850mg, 1000mg

Blister, Rx, CTD
Tablets prolong. action (XR)

500mg, 750mg, 1000mg

Blister, Rx, EU CTD
More Less

Sitagliptin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

100mg

Blister, Rx, EU CTD
More Less

Sitagliptin + Metformin

Drugs used in Diabetes

Film-coated Tablets

Film-coated Tablets

50mg+850mg, 50mg+1000mg

Blister, Rx, EU CTD
More Less

Thioctic acid

Drugs used in Diabetes

Conc. for Infusion Solution Solution for Infusion Film-coated Tablets (НR)

Conc. for Infusion Solution

3%: 10mL, 20mL

Ampoule, Rx, CTD
Solution for Infusion

1.2%: 50mL

Vial, Rx, CTD
Film-coated Tablets (НR)

600mg

Blister, Rx, EU CTD
More Less

At Farmak International, diabetes pharmaceuticals are developed and manufactured under EU GMP certification. As an antidiabetic drug distributor, we offer diabetes care products.

Comprehensive Oral Antidiabetic Portfolio

Our range of medications is designed to target the various pathophysiological defects of Type 2 Diabetes. Our portfolio is divided into the following core classes:

  • SGLT2 inhibitors (the latest recommended guidelines). They are based on the effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i). In addition to lowering blood sugar, these medications prevent heart failure, delay chronic kidney disease progression, and reduce cardiovascular mortality. As an SGLT2 inhibitor supplier, we offer Dapagliflozin, Dapagliflozin + Metformin, Empagliflozin, Empagliflozin + Metformin, and Ipragliflozin. If you are looking for a dapagliflozin distributor in Europe, we are open to cooperation.
  • DPP-4 inhibitors for glucose control. They block the DPP-4 enzyme, which increases incretin hormone levels, stimulates insulin production after meals, and suppresses glucagon secretion. As a DPP-4 inhibitor distributor, we deliver Sitagliptin and Sitagliptin + Metformin. Being a Metformin distributor and manufacturer, we produce tablets of prolonged action, known as Metformin XR extended-release.
  • Sulfonylureas. As a Sulfonylureas supplier, we offer this class when it is required to stimulate insulin secretion. We are a Gliclazide distributor and a Glimepiride supplier.
  • Alpha-lipoic acid. Alpha-lipoic acid distributors ask for this product class when they are looking for powerful antioxidants used in diabetic neuropathy treatment. These agents are needed to reduce symptoms, such as pain, numbness, and burning. We are a Thioctic acid supplier. Thioctic acid is the more traditional chemical name for alpha-lipoic acid, which is frequently used in Europe.
  • Diagnostic products. Dextrose is used for an oral glucose tolerance test to provide a standard, controlled sugar load.

We provide fixed-dose combinations intended to simplify type 2 diabetes treatments. FDCs significantly reduce the total number of medications or doses a patient must take daily. Additionally, they bring blood sugar levels into their recommended, healthy range faster.

Hospital & Institutional Diabetes Care Applications

We deliver our type 2 diabetes medications to institutional organisations and diabetes medication supplier hospitals, including sitagliptin supplier hospitals. Institutional diabetes care applications also include:

  • hospital diabetes management protocols;
  • primary care integration for chronic disease management;
  • heart failure and CKD programs (SGLT2i);
  • diabetic neuropathy treatment programs;
  • outpatient diabetes clinics;
  • discharge medication planning.

We are not a direct endocrinology department supplier but offer our products for inclusion in the diabetes formulary supply. This specific list of medications is used by hospitals for routine stocking.

Product Specifications & Formulation Options

All our products are manufactured in tablets or liquids with different concentrations. Multiple strengths allow for flexible dosing. There are the following formulations:

  • Oral tablets. This form of oral hypoglycemic agents is convenient to take. Tablets can be film-coated, with prolonged action (XR), and with modified release (MR).
  • Fixed-dose combinations (metformin + SGLT2i/DPP-4i). They facilitate diabetes combination therapy by reducing the daily pill burden.
  • Injectable thioctic acid for neuropathy. This route is better for faster onset of action and better availability.
  • Unit-dose powder for oral solution in a sachet. This format ensures precise dosing, stability, and fast absorption.

We package our generic diabetes drugs, using hospital and retail options. We provide sterility in glass ampules and vials. To ensure stability and prevent degradation, we strictly adhere to the standard storage requirements.

Quality Standards & Evidence-Based Therapy

Our diabetes drug manufacturing is GMP-certified and highly regulated to ensure that all medications are consistently produced and thoroughly packaged. Quality assurance and regulatory compliance aren’t separate checkpoints, they’re built into every stage of development and manufacturing. This integrated approach ensures consistent product performance and regulatory alignment across international distribution networks. 

Diabetes Pharmaceutical Supply Partnership

At Farmak International, we offer the most efficient, modern diabetes therapies and ensure a reliable supply chain. We deliver our products to Europe, MENA, and Central Asia, following basic precautions required to ensure the medications maintain their effectiveness. Our partners benefit from:

  • comprehensive and well-balanced antidiabetic CTD-ready portfolio;
  • tested and validated high-quality products;
  • competitive pricing that facilitates chronic disease management;
  • fixed-dose combinations for more efficient treatment;
  • professional forwarding agents ensuring hassle-free customs formalities.

When needed, we are ready to offer technical support for diabetes care teams. To place an order or discuss partnership terms, please contact us via email or by phone: +(41 41 541 0268).